Drug-phytochemical interactions

Inflammopharmacology

Volumn 11, Issue 1, 2003, Pages 7-42

  Ioannides, Costas ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Biotransformation; Cytochrome P450; Dietary supplements; Phytochemicals

Indexed keywords

3 INDOLEMETHANOL; ALPRAZOLAM; AMITRIPTYLINE; CARBAMAZEPINE; CYCLOSPORIN; CYTOCHROME P450; DIGOXIN; FEXOFENADINE; FURAFYLLINE; GARLIC EXTRACT; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; INDINAVIR; LIMONENE; MENTHOL; NEVIRAPINE; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PHENACETIN; PHENPROCOUMON; PLANT EXTRACT; PSORALEN; RIFAMPICIN; SECOBARBITAL; SIMVASTATIN; TERFENADINE; THEOPHYLLINE DERIVATIVE; UNINDEXED DRUG; WARFARIN; XENOBIOTIC AGENT;

AREA UNDER THE CURVE; BIOTRANSFORMATION; CABBAGE; DIET SUPPLEMENTATION; DRUG ABSORPTION; DRUG ACTIVITY; DRUG HALF LIFE; DRUG METABOLISM; FIRST PASS EFFECT; FOOD DRUG INTERACTION; GARLIC; GRAPEFRUIT JUICE; HERBAL MEDICINE; HUMAN; PHYTOCHEMISTRY; PRIORITY JOURNAL; REVIEW; VEGETABLE; XENOBIOTIC METABOLISM;

EID: 0038317909     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1163/156856003321547103     Document Type: Review

References (213)

1. Ameer, B. and Weintraub, R. A. (1997). Drug interactions with grapefruit juice, Clin. Pharmacokin. 33, 103-121.
2. Ames, B. N. and Gold, L. S. (1998). The prevention of cancer, Drug Metab. Rev. 30, 201-223.
3. Ayalogu, E. O., Snelling, J., Lewis, D. F. V., et al. (1995). Induction of hepatic CYP1A2 by the oral administration of caffeine to rats: lack of association with the Ah locus, Biochim. Biophys. Acta 1272, 89-94.
4. Ayrton, A. D. and Morgan, P. (2001). Role of transport proteins in drug absorption, distribution and excretion, Xenobiotica 31, 469-497.
5. Ayrton, A. D., Ioannides, C. and Walker, R. (1988). Induction of rat hepatic cytochrome P-450I proteins by the antimutagen anthraflavic acid, Food Chem. Toxicol. 26, 909-915.
6. Bailey, D. G., Spence, J. D., Munoz, C., et al. (1991). Interaction of citrus juices with felodipine and nifedipine, Lancet 337, 268-269.
7. Bailey, D. G., Malcolm, J., Arnold, O., et al. (1998a). Grapefruit juice-drug interactions, Br. J. Clin. Pharmacol. 46, 101-110.
8. Bailey, D. G., Kreeft, J. H., Munoz, C., et al. (1998b). Grapefruit juice-felodipine interaction: effect of naringin and 6′,7′-dihydrobergamottin in humans, Clin. Pharmacol. Ther. 64, 248-256.
9. Bailey, D. G., Dresser, G. K., Kreeft, J. H., et al. (2000). Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients, Clin. Pharmacol. Ther. 68, 468-477.
10. Ball, S. E., Forrester, L. M., Wolf, C. R., et al. (1990). Differences in the cytochrome P-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17α-ethinyloestradiol, Biochem. J. 267, 221-6.
11. Bano, G., Amla, V., Raina, R. K., et al. (1987). The effect of piperine on pharmacokinetics of phenytoin in healthy volunteers, Planta Med. 53, 568-569.
12. Bano, G., Raina, R. K., Zutshi, U., et al. (1991). Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers, Eur. J. Biochem. 41, 615-617.
13. Barceló, S., Gardiner, J. M., Gescher, A., et al. (1996). CYP2E1-mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane, Carcinogenesis 17, 277-282.
14. Barceló, S., Macé, K., Pfeifer, A. M. A., et al. (1998). Production of DNA strand breaks by N-nitrosodimethylamine and 2-amino-3-methylimidazo[4,5-f]quinoline in THLE cells expressing human CYP isoenzymes and inhibition by sulphoraphane, Mutation Res. 402, 111-120.
15. Barnes, J. Anderson, L. A. and Phillipson, J. D. (2001). St. John's wort (Hypericum perforatum L.): A review of its chemistry, pharmacology and clinical properties, J. Pharm. Pharmacol. 53, 583-600.
16. Barone, J. J. and Roberts, H. R. (1996). Caffeine consumption, Food Chem. Toxicol. 34, 119-129.
17. Barone, G. W., Curley, B. J., Ketel, B. L., et al. (2000). Drug interaction between St. John's wort and cyclosporine, Ann. Pharmacother. 34, 1013-1016.
18. Barone, G. W., Curley, B. J., Ketel, B. L., et al. (2001). Herbal supplements: a potential for drug interactions in transplant recipients, Transplantation 71, 239-241.
19. Benton, R. E., Honig, P. K., Zamani, K., et al. (1996). Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram, Clin. Pharmacol. Ther. 59, 383-388.
20. Bjeldanes, L. F., Kim, J.-Y., Grose, K. R., et al. (1991). Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: Comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin, Proc. Natl. Acad. Sci. USA 88, 9543-9547.
21. Block, G., Patterson, B. and Subar, A. (1992). Fruit, vegetables and cancer prevention: a review of the 41 epidemiological evidence, Nutr. Cancer 18, 1-29.
22. Blumenthal, M. (1999). Herb market levels after five years of boom, Herbal Gram. 47, 64-65.
23. Bogman, K., Peyer, A. K., Török, M., et al. (2001). HMG-CoA reductase inhibitors and Pglycoprotein modulation, Br. J. Pharmacol. 132, 1183-1192.
24. Bolt, H. M. (1994). Interactions between clinically used drugs and oral contraceptives, Environm. Health Persp. 102, 35-38.
25. Bradfield, C. A. and Bjeldanes, L. F. (1987). Structure-activity relationships of dietary indoles: a proposed mechanism of action as modifiers of xenobiotic metabolism, J. Toxicol. Environm. Health 21, 311-323.
26. Brady, J. F., Wang, M.-H., Hong, J.-Y., et al. (1991a). Modulation of rat hepatic microsomal monooxygenase activities and cytotoxicity by diallyl sulphide, Toxicol. Appl. Pharmacol. 108, 342-354.
27. Brady, J. F., Ishizaki, H., Fukuto, J. M., et al. (1991b). Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites, Chem. Res. Toxicol. 4, 642-647.
28. Bray, B. J., Perry, N. B., Menkes, D. B., et al. (2002a). St. John's wort extract induces CYP3A and CYP2E1 in the Swiss Webster mouse, Toxicol. Sci. 66, 27-33.
29. Bray, B. J., Brennan, N. J., Perry, N. B., et al. (2002b). Short treatment with St. John's wort, hypericin or hyperforin fails to induce CYP450 isoforms in the Swiss Webster mouse, Life Sci. 70, 1325-1335.
30. Breidebach, Th., Kliem, V., Burg, M., et al. (2000). Profound drop of cyclosporin A whole blood levels caused by St. John's wort (Hypericum perforatum), Transplantation 69, 2229-2232.
31. Bu-Abbas, A., Clifford, M. N., Walker, R., et al. (1998). Contribution of caffeine and flavanols in the induction of hepatic phase II activities by green tea, Food Chem. Toxicol. 36, 617-621.
32. Bu-Abbas, A., Copeland, E., Clifford, M. N., et al. (1999). Cytochrome P450 induction by tea, and its consequences on the bioactivation of chemical carcinogens: contribution of caffeine and flavanols, Environm. Toxicol. Pharmacol. 7, 41-47.
33. Budzinski, J. W., Foster, B. C., Vandenhoek, S., et al. (2000). An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures, Phytomedicine 7, 273-282.
34. Cai, Y. N., Bennett, D., Nair, R. V., et al. (1993). Inhibition and inactivation of murine hepatic ethoxy- and pentoxyresorufin O-dealkylase by naturally occurring coumarins, Chem. Res. Toxicol. 6, 872-879.
35. Canivenc-Lavier, M-C., Vernevaut, M-F., Totis, M., et al. (1996). Comparative effects of flavonoids and model inducers on drug-metabolizing enzymes in rat liver, Toxicology 114, 19-27.
36. Carson, S. W., Hill-Zabala, C. E., Roberts, S. H., et al. (2000). Inhibitory effect of methanolic solution of St. John's wort (Hypericum perforatum) on cytochrome P450 3A4 activity in human liver microsomes, Clin. Pharmacol. Ther. 67, PI39.
37. Cashman, J. R. (2002). Flavin monooxygenases, in: Enzyme Systems that Metabolise Drugs and Other Xenobiotics, C. Ioannides (Ed.), pp. 67-93. John Wiley, Chichester.
38. Cashman, J. R., Xiong, Y., Lin, J., et al. (1999). In vitro and in vivo inhibition of human flavin-containing monooxygenase form 3 (FMO3) in the presence of dietary indoles, Biochem. Pharmacol. 58, 1047-1055.
39. Chan, W. K., Nguyen, L. T., Miller, V. P., et al. (1998). Mechanism-based inactivation of human cytochrome P450 3A4 by grapefruit juice and red wine, Life Sci. 62, 135-142.
40. Chang, T. K. H., Chen, J. and Lee, W. B. K. (2001). Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: Evidence for mechanism-based inactivation of CYP1A2, J. Pharmacol. Exp. Ther. 299, 874-882.
41. Chiba, M., Hensleigh, M., Nishime, J. A., et al. (1996). Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor, Drug Metab. Dispos. 24, 307-314.
42. Christians, U., Jacobsen, W. and Floren, L. C. (1998). Metabolism and drug interactions of 3-hydroxy-3-metdhylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar?, Pharmacol. Ther. 80, 1-34.
43. Conseil, G., Baubichon-Cortay, H., Dayan, G., et al. (1998). Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein, Proc. Natl. Acad. Sci. USA 95, 9831-9836.
44. Crone, C. C. and Wise, T. N. (1997). Survey of alternative medicine use among organ transplant patients, J. Transplant. Coord. 7, 123-130.
45. Cvetkovic, M., Leake, B., Fromm, M. F., et al. (1999). OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine, Drug Met. Disp. 27, 866- 871.
46. de Kruif, C. A., Marsman, J. W., Venekamp, J. C., et al. (1991). Structure elucidation of acid reaction products of indole-3-carbinol: detection in vivo and enzyme induction in vitro, Chem.-Biol. Interact. 80, 303-315.
47. de los Reyes, G. C. and Koda, R. T. (2002). Determining hyperforin and hypericin content in eight brands of St. John's wort, Am. J. Health-Syst. Pharm. 59, 545-547.
48. de Maat, M. M. R., Hoetelmans, R. M. W., Mathôt, R. A. A., et al. (2001). Drug interaction between St. John's wort and nevirapine, AIDS 15, 420-421.
49. Decker, C. J., Laitinen, L. M., Bridson, G. W., et al. (1998). Metabolism of amprenavir in liver microsomes: Role of CYP3A4 inhibition for drug interactions, J. Pharm. Sci. 87, 803-807.
50. Di Pietro, A., Conseil, G., Pérez-Victoria, J. M., et al. (2002). Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters, Cell Mol. Life Sci. 59, 307-322.
51. Dragnev, K. H., Nims, R. W. and Lubet, R. A. (1995). The chemopreventive agent diallyl sulfide. A structurally atypical phenobarbital-type inducer, Biochem. Pharmacol. 50, 2099-2104.
52. Dresser, G. K., Bailey, D. G., Leake, B. F., et al. (2002). Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine, Clin. Pharmacol. Ther. 71, 11-20.
53. Ducharme, M. D., Warbasse, L. H. and Edwards, D. J. (1995). Disposition of intravenous and oral cyclosporine after administration with grapefruit juice, Clin. Pharmacol. Ther. 57, 485-491.
54. Dürr, D., Stieger, B., Kullak-Ublick, G. A., et al. (2000). St. John's wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4, Clin. Pharmacol. Ther. 68, 598-604.
55. Edwards, D. J., Bellevue Iii, F. H. and Woster, P. M. (1996). Identification of 6′7′-dihydroxybergamottin a cytochrome P450 inhibitor, in grapefruit juice, Drug Metab. Dispos. 24, 1287-1290.
56. Edwards, D. J., Fitzsimmons, M. E., Schuetz, E. G., et al. (1999). 6′,7′-Dihydroxybergamottin in grapefruit juice and Seville orange juice: Effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein, Clin. Pharmacol. Ther. 65, 237-244.
57. Embola, C. W., Weisburger, M. C. and Weisburger, J. H. (2001a). Green tea and the metabolism of 2-amino-3-methylimidazo[4,5-f]quinoline in F344 rats, Food Chem. Toxicol. 39, 629-633.
58. Embola, C. W., Weisburger, J. H. and Weisburger, M. C. (2001b). Urinary excretion of N-OH-2-amino-3-methylimidazo[4,5-f]quinoline-N-glucuronide in F344 rats is enhanced by green tea, Carcinogenesis 22, 1095-1098.
59. EMEA (1999). Report from the Ad Hoc Working Group on Herbal Medicinal Products, European Medicine Evaluation Agency.
60. Erickson, D. A., Mather, G., Trager, W. F., et al. (1999). Chacterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450, Drug Metab. Dispos. 27, 1488-1495.
61. Ernst, E. (1999). Second thoughts about safety of St. John's wort, Lancet 354, 2014-2016.
62. Fitzsimmons, M. E. and Collins, J. M. (1997). Selective biotransformation of the human immunodeficiency virus protease inhibitor sequinavir by human small-intestinal cytochrome P4503A4-potential contribution to high first-pass metabolism, Drug Metab. Dispos. 25, 256-266.
63. Forkert, P.-G., Premdas, P. D. and Bowers, R. J. (2000). Epoxide formation from diallyl sulfone is associated with CYP2E1 inactivation in murine and human lungs, Am. J. Respir. Cell Mol. Biol. 23, 687-695.
64. Fugh-Berman, A. and Ernst, E. (2001). Herb-drug interactions: Review and assessment of report reliability, Br. J. Clin. Pharmacol. 52, 587-595.
65. Fuhr, U. (1998). Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance, Drug Safety 18, 251-272.
66. Fuhr, U. (2000). Induction of drug metabolising enzymes. Pharmacokinetic and toxicological consequences in humans, Clin. Pharmacokinet. 38, 493-504.
67. Fuhr, U., Doehmer, J., Battula, N, et al. (1992). Biotransformation of caffeine and theophylline in mammalian-cell lines genetically engineered for expression of single cytochrome-P450 isoforms, Biochem. Pharmacol. 43, 225-235.
68. Fuhr, U., Klittich, K. and Staib, A. H. (1993). Inhibitory effect of grapefruit juice and the active component, naringenin, on CYP1A2 dependent metabolism of caffeine, Br. J. Clin. Pharmacol. 35, 431-436.
69. Fuhr, U., Maier, A., Keller, A., et al. (1995). Lacking effect of grapefruit juice on theophylline pharmacokinetics, Intern. J. Clin. Pharmacol. Ther. 33, 311-314.
70. Fukuda, K., Ohta, T., Oshima, Y., et al. (1997). Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction, Pharmacogenetics 7, 391-396.
71. Galijatovic, A., Otake, Y., Walle, U. K., et al. (2001). Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoids chrysin in Caco-2 cells - potential role in carcinogen bioactivation, Pharm. Res. 18, 374-379.
72. Gillner, Mm, Bergman, J., Cambilau, C., et al. (1985). Interaction of indoles with binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver, Mol. Pharmacol. 28, 357-363.
73. Glatt, H. (2002). Sulphotransferases, in: Enzyme Systems that Metabolise Drugs and Other Xenobiotics, C. Ioannides (Ed.), pp. 353-439. John Wiley, Chichester.
74. Goasduff, T., Dréano. Y, Guillois. B., et al. (1996). Induction of liver and kidney CYP1A1/1A2 by caffeine in rat, Biochem. Pharmacol. 52, 1915-1919.
75. Goosen, T. C., Mills, D. E. and Hollenberg, P. F. (2001). Effects of benzyl isothiocyanate on rat and human cytochrome P450: Identification of metabolites formed by cytochrome P450 2B1, J. Pharmacol. Exp. Ther. 296, 198-206.
76. Gruenwald, J. (2000). The supplement markets in the US and Europe, Neutrachem. World (July/August), 36-37.
77. Guengerich, F. P. (1988). Oxidation of 17α-ethynyloestradiol by human liver cytochrome P-450, Mol. Pharmacol. 33, 500-508.
78. Guo, Z., Smith, T. J., Wang, E., et al. (1992). Effects of phenethyl isothiocyanate, a carcinogenesis inhibitor, on xenobiotic-metabolizing enzymes and nitrosamine metabolism in rats, Carcinogenesis 13, 2205-2210.
79. Guo, L.-Q., Taniguchi, M., Chen, Q. Y., et al. (2000). Inhibitory effect of natural furanocoumarins on human microsomal cytochrome P450 3A activity, Jpn. J. Pharmacol. 82, 122-129.
80. Guo, L.-Q., Taniguchi, M., Chen, Q. Y., et al. (2001). Inhibitory potential of herbal medicines on human cytochrome P450-mediated oxidation: Properties of Umbelliferous or Citrus crude drugs and their relative prescriptions, Jpn. J. Pharmacol. 85, 399-408.
81. Guyonnet, D., Siess, M.-H., Le Bon, A.-M., et al. (1999). Modulation of phase II enzymes by organosulfur compounds form Allium vegetables in rat tissues, Toxicol. Appl. Pharmacol. 154, 50-58.
82. Guyonnet, D., Belloir, C., Suscetet, M., et al. (2000). Liver subcellular fractions from rats treated by organosulfur compounds from Allium modulate mutagen activation, Mutation Res. 466, 17-26.
83. Gwilt, P. R., Lear, C. L., Tempero, M. A., et al. (1994). The effect of garlic extract on human metabolism of acetaminophen, Cancer Epidemiol. Biomark. Prevent. 3, 155-160.
84. Haber, D., Siess, M.-H., De Waziers, I., et al. (1994). Modification of hepatic drug-metabolizing enzymes in rats fed naturally occurring allyl sulphides, Xenobiotica 24, 169-182.
85. Haber, D., Siess, M. H., Canivenc-Lavier, M. C., et al. (1995). Differential effects of diallyl sulfide and diallyl disulfide on rat intestinal and hepatic drug-metabolizing enzymes, J. Toxicol. Environm. Health 44, 423-434.
86. He, K., Iyer, K. R., Hayes, R. N., et al. (1998). Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice, Chem. Res. Toxicol. 11, 252-259.
87. Hollt, V., Kouba, M., Dietel, M., et al. (1992). Stereoisomers of calcium-antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein, Biochem. Pharmacol. 43, 2601-2608.
88. Honig, P. K., Wortham, D. C., Zamani, K., et al. (1993). Terfenadine-ketoconazole interaction: pharmacokinetic and electrocardiographic consequences, J. Am. Med. Ass. 269, 1513-1518.
89. Hoult, J. R. S. and Payá, M. (1996). Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential, Gen. Pharmacol. 27, 713-722.
90. Huang, O., Lawson, T. A., Chung, F. L., et al. (1993). Inhibition by phenylethyl and phenylhexyl isothiocyanates of metabolism and DNA methylation by N-nitrosomethylamylamine in rats, Carcinogenesis 14, 749-754.
91. Hukkinen, S. K., Varhe, A., Olkkola, K. T., et al. (1995). Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice, Clin. Pharmaco. Ther. 58, 127-131.
92. Hulla, J. E. and Juchau, M. R. (1989). Developmental aspects of P450IIIA: Prenatal activity and inducibility, Drug Metab. Rev. 20, 765-779.
93. Ioannides, C. (Ed.) (2002a). Enzyme Systems that Metabolise Drugs and Other Xenobiotics. John Wiley, Chichester, UK.
94. Ioannnides, C. (2002b). Pharmacokinetic interactions between herbal remedies and medicinal drugs, Xenobiotica 32, 451-478.
95. Ioannides, C., Delaforge, M. and Parke, D. V. (1981). Safrole: its metabolism, carcinogenicity and interactions with cytochrome P-450, Food Cosmetic Toxicol. 19, 657-666.
96. Ioannides, C., Barnett, C. R., Irizar, A., et al. (1996). Expression of cytochrome P450 proteins in disease, in: Cytochromes P450: Metabolic and Toxicological Aspects, C. Ioannides (Ed.), pp. 301-327. CRC Press, Boca Raton, FL.
97. Ishizaki, H., Brady, J. F., Ning, S. M., et al. (1990). Effect of phenethyl isothiocyanate on microsomal N-nitrosodimethylamine (NDMA) metabolism and other monooxygenase activities, Xenobiotica 20, 255-264.
98. Jellinck, P. H., Forkert, P. G., Riddick, D. S., et al. (1993). Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation, Biochem. Pharmacol. 45, 1129-1136.
99. Jin, L. and Baillie, T. A. (1997). Metabolism of the chemopreventive agent diallyl sulphide to glutathione conjugates in rats, Chem. Res. Toxicol. 10, 318-327.
100. Johne, A., Brockmöller, J., Bauer, S., et al. (1999a). Interaction of St. John's wort extract with digoxin, Eur. J. Clin. Pharmacol. 55, A22.
101. Johne, A., Brockmöller, J., Bauer, S., et al. (1999b). Pharmacokinetic interaction of digoxin with an herbal extract from St. John's wort (Hypericum perforatum), Clin. Pharmacol. Ther. 66, 338-345.
102. Johne, A., Schmider, J., Brockmoller, J., et al. (2002). Decreased plasma levels of amitriptyline and its metabolites on co-medication with an extract from St. John's wort (Hypericum perforatum), J. Clin. Psychopharmacol. 22, 46-54.
103. Josey, E. S. and Tackett, R. L. (1999). St. John's wort: A new alternative for depression, Intern. J. Clin. Pharmacol. Ther. 37, 111-119.
104. Kall, M. A., Vang, O. and Clausen, J. (1996). Effects of dietary broccoli on human in vivo drug metabolizing enzymes: evaluation of caffeine, oestrone and chlorzoxazone metabolism, Carcinogenesis 17, 793-799.
105. Kaminsky, L. C. and Zhang, Z. Y. (1997). Human P450 metabolism of warfarin, Pharmacol. Ther. 73, 67-74.
106. Kanazawa, S., Ohkubo, T. and Sugawara, K. (2001). The effects of grapefruit juice on the pharmacokinetics of erythromycin, Eur. J. Clin. Pharmacol. 56, 799-803.
107. Kang, M. H., Won, S. M., Park, S. S., et al. (1994). Piperine effects on the expression of P4502E1, cytochrome P4502B and P4501A, Xenobiotica 24, 1195-1204.
108. Kantola, T., Kivistö, K. T. and Neuvonen, P. J. (1998). Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid, Clin. Pharmacol. Ther. 63, 394-402.
109. Karliova, M., Treichel, U., Malagò, M., et al. (2000). Interaction of Hypericum perforatum (St. John's wort) with cyclosporin A metabolism in a patient after liver transplantation, J. Hepatol. 33, 853-855.
110. Katchamart, S. and Williams, D. E. (2001). Indole-3-carbinol modulation of hepatic monooxygenases CYP1A1, CYP1A2 and FMO1 in guinea pig, mouse and rabbit, Comp. Biochem. Biophys. 129, 377-384.
111. Katchamart, S., Stresser, D. M., Dehal, S. S., et al. (2000). Concurrent flavin-containing monooxygenase down-regulation and cytochrome P-450 induction by dietary indoles in rat: implications for drug-drug interaction, Drug Metab. Dispos. 28, 930-936.
112. Kim, R. B., Wandel, C., Leake, B., et al. (1999). Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein, Pharm. Res. 16, 408-414.
113. Koenigs, L. L. and Trager, W. F. (1998a). Mechanism-based inactivation of cytochrome P450 2B1 by 8-methoxypsoralen and several other furanocoumarins, Biochemistry 37, 13184-13193.
114. Koenigs, L. L. and Trager, W. F. (1998b). Mechanism-based inactivation of P450 2A6 by furanocoumarins, Biochemistry 37, 10047-10061.
115. Kolars, J. C., Stetson, P. L., Rush, B. D., et al. (1992a). Cyclosporine metabolism of P450IIIA in rat enterocytes - another determinant of oral bioavailability, Transplantation 53, 596-602.
116. Kolars, J. C., Schmiedlin-Ren, P., Schuetz, J. D., et al. (1992b). Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes, J. Clin. Invest. 90, 1871-1878.
117. Kupferschmidt, H., Ha, H., Ziegler, W., et al. (1995). Interaction between grapefruit juice and midazolam in humans, Clin. Pharmacol. Ther. 58, 20-28.
118. Kupferschmidt, H. H., Fattinger, K. E., Ha, H. R., et al. (1998). Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man, Br. J. Clin. Pharmacol. 45, 355-359.
119. Kurth, H. and Spreemann, R. (1998). Phytochemical characterization of various St. John's Wort extracts, Adv. Ther. 15, 117-128.
120. Kwak, M. K., Kim, S. G., Kwak, J. Y., et al. (1994). Inhibition of cytochrome P4502E1 expression by organosulfur compounds allylsulfide, allylmercaptan and allyl methylsulfide in rats, Biochem. Pharmacol. 47, 531-539.
121. Lacarelle, B., Rahmani, R., Desousa, G., et al. (1991). Metabolism of digoxin, digoxigenin digitoxosides and digoxigenin in human hepatocytes and liver microsomes, Fundam. Clin. Pharmacol. 5, 567-582.
122. Lampe, J. W., King, I. B., Li, S., et al. (2000). Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 in humans: changes in caffeine metabolite ratios in response to controlled vegetable diets, Carcinogenesis 21, 1157-1162.
123. Langouët, S., Furge, L. L., Kerriguy, N., et al. (2000). Inhibition of human cytochrome P450 enzymes by 1,2-dithiole-3-thione, oltipraz and its derivatives, and sulphoraphane, Chem. Res. Toxicol. 13, 245-252.
124. Larsen-Su, S. A. and Williams, D. E. (2001). Transplacental exposure to indole-3-carbinol induces sex-specific expression of CYP1A1 and CYP1B1 in the liver of Fischer 344 neonatal rats, Toxicol. Sci. 64, 162-168.
125. Levy, G. N. and Weber, W. W. (2002). Arylamine acetyltransferases, in: Enzyme Systems that Metabolise Drugs and Other Xenobiotics, C. Ioannides (Ed.), pp. 441-457. John Wiley, Chichester.
126. Lewis, D. F. V., Eddershaw, P. J., Goldfarb, P. J., et al. (1996). Molecular modelling of CYP3A4 from an alignment with CYP102: identification of key interactions between putative active site residues and CYP3A-specific chemicals, Xenobiotica 26, 1067-1086.
127. Lilja, J. J., Kivistö, K. T. and Neuvonen, P. J. (1998). Grapefruit juice-simvastatin interaction; effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors, Clin. Pharmacol. Ther. 64, 477-483.
128. Lilja, J. J., Kivistö, K. T., Backman, J. T., et al. (2000a). Effect of grapefruit dose on grapefruit juice-triazolam interaction, Eur. J. Clin. Pharmacol. 56, 411-415.
129. Lilja, J. J., Kivistö, K. T. and Neuvonen, P. J. (2000b). Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin, Clin. Pharmacol. Ther 68, 384-390.
130. Lin, J. H. and Lu, A. Y. H. (1998). Inhibition and induction of cytochrome P450 and the clinical implications, Clin. Pharmacokinet. 35, 361-390.
131. Litman, T., Zeuthen, T., Skovsgaard, T., et al. (1997). Competitive, non-competitive and cooperative interactions between substrates of P-glycoprotein as measured by its ATPase activity, Biochim. Biophys. Acta 1361, 169-176.
132. Liu, E. H., Turner, L. M., Lin, S. X., et al. (2000). Use of alternative medicine by patients undergoing cardiac surgery, J. Thorac. Cardiov. Surg. 120, 335-341.
133. Loizou, G. D. and Cocker, J. (2001). The effect of alcohol and diallyl suphide on CYP2E1 activity in humans: a phenotyping study using chlorzoxazone, Human Exp. Toxicol. 20, 321-327.
134. Longo, V., Amato, G., Salvetti, A., et al. (2000). Heterogeneous effects of anthraquinones on drug-metabolizing enzymes in the liver and small intestine of rat. Chem.-Biol. Interact. 126, 63-77.
135. Lown, K. S., Bailey, D. G., Fontana, R. J., et al. (1997). Grapefruit juice increases felodipine oral bioavailability in humans by decreasing intestinal CYP3A protein expression, J. Clin. Invest. 99, 2545-2553.
136. Lundahl, J., Regårdh, C. G., Edgar, B., et al. (1995). Relationship between the time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects, Eur. J. Clin. Pharmacol. 49, 61-67.
137. Mahéo, K., Morewl, F., Langouët, S., et al. (1997). Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulphoraphane in primary human and rat hepatocytes, Cancer Res. 57, 3649-3652.
138. Mai, I., Krüger, H., Budde, K., et al. (2000). Hazardous pharmacokinetic interaction of St. John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin, Int. J. Clin. Pharmacol. Ther. 38, 500-502.
139. Malhotra, S. Bailey, D. G., Paine, M. F., et al. (2001). Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furanocoumarins, Clin. Pharmacol. Ther. 69, 14-23.
140. Maltzman, T. H., Christou, M., Gould, M. N., et al. (1991). Effects of monoterpenoids on in vivo DMBA-DNA adduct formation and on phase I hepatic metabolizing enzymes, Carcinogenesis 12, 2081-2087.
141. Marchetti, F., De Santi, C., Vietri, M., et al. (2002). Differential inhibition of human liver and duodenum sulphotransferase activities by quercetin, a flavonoid present in vegetables, fruit and wine, Xenobiotica 31, 841-847.
142. Maurer, A., Johne, A., Bauer, S., et al. (1999). Interaction of St. John's wort extract with phenprocoumon, Eur. J. Clin. Pharmacol. 55, A22.
143. McArdle, N. J., Clifford, M. N. and Ioannides, C. (1999). Consumption of tea modulates the urinary excretion of mutagens in rats treated with IQ. Role of caffeine, Mutation Res. 441, 197-203.
144. McDanell, R., McLean, A. M., Hanley, A. B., et al. (1987). Differential induction of mixed-function oxidase (MFO) in rat liver and intestine by diets containing processed cabbage: correlation with cabbage levels of glucosinolates and glucosinolate hydrolysis products, Food Chem. Toxicol. 25, 363-368.
145. McDanell, R., McLean, A. E. M., Hanley, A. B., et al. (1990). The effect of feeding Brassica vegetables and intact glucosinolates on mixed-function oxidase activity in the livers and intestines of rats. Food Chem. Toxicol. 27, 289-293.
146. McDanell, R. E., Henderson, L. A., Russell, K., et al. (1992). The effect of Brassica vegetable consumption of caffeine metabolism in humans, Human Exp. Toxicol. 11, 167-172.
147. Merkel, U., Sigusch, U. and Hoffmann, A. (1994). Grapefruit juice inhibits 7-hydroxylation of coumarin in healthy volunteers, Eur. J. Clin. Pharmacol. 46, 175-177.
148. Min, D. I., Ku, Y.-M., Geraets, D. R., et al. (1996). Effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of quinidine in healthy volunteers, J. Clin. Pharmacol. 36, 469-476.
149. Mohri, K. and Uesawa, Y. (2001). Effects of furanocoumarins derivatives in grapefruit juice on nifedipine pharmacokinetics in rats, Pharm. Res. 18, 177-182.
150. Moore, L. B., Goodwin, B., Jones, S. A., et al. (2000). St. John's wort induces drug metabolism through activation of the pregnane X receptor, Proc. Natl. Acad. Sci. USA 97, 7500-7502.
151. Moreno, R. L., Goosen, T., Kent, U. M., et al. (2001). Differential effects of naturally occurring isothiocyanates on the activities of cytochrome P450 2E1 and the mutant P450 2E1 T303A, Arch. Biochem. Biophys. 391, 99-110.
152. Mori, H. and Nishikawa, H. (1998). Naturally occurring organosulphur compounds as potential anticarcinogens, in: Nutrition and Chemical Toxicity, C. Ioannides (Ed.), pp. 285-299. John Wiley, Chichester.
153. Munday, R. and Munday, C. M. (1999). Low doses of diallyl sulfide, a compound derived from garlic, increase tissue activities of quinone reductase and glutathione transferase in the gastrointestinal tract of the rat, Nutr. Cancer 34, 42-48.
154. Murray, M. (1992). P450 enzymes: inhibition mechanisms, genetic regulation and effects of liver disease, Clin. Pharmacokinet. 23, 132-146.
155. Murray, M. and Reidy, G. F. (1990). Selectivity in the inhibition of mammalian cytochromes P-450 by chemical agents, Pharmacol. Rev. 42, 85-101.
156. Nakajima, M., Yoshida, R., Shimada, N., et al. (2001). Inhibition and inactivation of human cytochrome P450 isoforms by phenethyl isothiocyanate, Drug Met. Disp. 29, 1110-1113.
157. Nebel, A., Schneider, B. J., Baker, R. K., et al. (1999). Potential metabolic interaction between St. John's wort and theophylline, Ann. Pharmacother. 33, 502.
158. Nöldner, M. and Chatterjee, S. (2001). Effects of two different extracts of St. John's wort and some of their constituents on cytochrome P450 activities in rat liver microsomes, Pharmacopsychiatry 34, S108-S110.
159. Obermeier, M. T., White, R. E. and Yang, C. S. (1995). Effects of bioflavonoids on hepatic P450 activities, Xenobiotica 25, 575-584.
160. Olesen, O. V. and Linnet, K. (1997). Metabolism of the tricyclic antidepressant amitriptyline by cDNA-expressed human cytochrome P450 enzymes, Pharmacology 55, 235-243.
161. Pantuck, E. J., Pantuck, E. B., Garland, W. A., et al. (1979). Stimulatory effect of Brussel sprouts and cabbage on human drug metabolism, Clin. Pharmacol. Ther. 25, 88-95.
162. Pantuck, E. J., Pantuck, C. B., Anderson, K. E., et al. (1984). Effects of brussel sprouts and cabbage on drug conjugation, Clin. Pharmacol. Ther. 35, 161-169.
163. Parke, D. V. (1991). Nutritional requirements for detoxication of environmental chemicals, Food Add. Contamin. 8, 381-396.
164. Parke, D. V. and Ioannides, C. (1981). The role of nutrition in toxicology, Annu. Rev. Nutr. 1, 207-234.
165. Parke, D. V. and Ioannides, C. (1994). The effects of nutrition on chemical toxicity, Drug Metab. Rev. 26, 739-765.
166. Piscitelli, S. C., Burstein, A. H., Chaitt, D., et al. (2000). Indinavir concentrations and St. John's wort, Lancet 355, 547-548.
167. Premdas, P. D., Bowers, R. J. and Forkert, P. G. (2000). Inactivation of hepatic CYP2E1 by an epoxide of diallyl sulphone, J. Pharmacol. Exp. Ther. 293, 1112-1120.
168. Rampes, H., Sharples, F., Maragh, S., et al. (1997). Introducing complementary medicine into the medical curriculum, J. R. Soc. Med. 90, 19-22.
169. Reicks, M. M. and Crankshaw, D. L. (1996). Modulation of rat hepatic cytochrome P-450 activity by garlic organosulfur compounds, Nutr. Cancer 25, 242-248.
170. Roby, C. A., Anderson, G. D. Kantor, E., et al. (2000). St. John's wort: Effect on CYP3A4 activity, Clin. Pharmacol. Ther. 67, 451-457.
171. Ryan, D. E., Thomas, P. E. and Levin, W. (1980). Hepatic microsomal cytochrome P-450 from rats treated with isosafrole, J. Biol. Chem. 255, 7941-7955.
172. Ruschitzka, F., Meier, P. J., Turina, M., et al. (2000). Acute heart transplant rejection due to St. John's wort, Lancet 355, 548-549.
173. Salphati, L. and Benet, Z. (1999). Metabolism of digoxin and digoxigenin digitoxosides in rat liver microsomes: involvement of cytochrome P4503A, Xenobiotica 29, 171-185.
174. Schmiedlin-Ren, P., Edwards, D. J., Fitzsimmons, M. E., et al. (1997). Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents, Drug Metab. Dispos. 25, 1228-1233.
175. Schinkel, A. H., Waenaar, E., Van Deemter, L., et al. (1995). Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporine A, J. Clin. Invest. 96, 1698-1705.
176. Shader, R. I. and Greenblatt, D. J. (2000). More on oral contraceptives, drug interactions, herbal medicines, and hormone replacement therapy, J. Clin. Psychopharmacol. 20, 397-398.
177. Sherratt, P. J. and Hayes, J. D. (2002). Glutathione S-transferases, in: Enzyme Systems that Metabolise Drugs and Other Xenobiotics, C. Ioannides (Ed.), pp. 319-352. John Wiley, Chichester.
178. Shertzer, H. G. (1982). Indole-3-carbinol and indole-3-acetonitrile influence on hepatic microsomal metabolism, Toxicol. Appl. Pharmacol. 64, 353-361.
179. Siebert, K. J., Troukhanova, N. V. and Lynn, P. Y. (1996). Nature of
180. Skiadas, P. K. and Lascaratos, J. G. (2001). Dietetics in ancient Greek philosophy: Plato's concepts of healthy diet, Eur. J. Clin. Nutr. 55, 532-537.
181. Skog, K. I. and Jägerstad, M. (1998). Toxicants in food: Generated during cooking, in: Nutrition and Chemical Toxicity, C. Ioannides (Ed.), pp. 59-79. John Wiley, Chichester.
182. Soldner, A., Christians, U., Susanto, M., et al. (1999). Grapefruit juice activates P-glycoproteinmediated drug transport, Pharm. Res. 16, 478-485.
183. Steinmetz, K. A., Kushi, L. H., Bostick, R. M., et al. (1994). Vegetables, fruit and colon cancer in the Iowa Women's Health Study, Am. J. Epidem. 139, 1-15.
184. 1 in the rat, Drug Metab. Dispos. 22, 383-391.
185. 1 exo-epoxide: association with reduced levels of hepatic aflatoxin-DNA adducts in vivo, Drug Metab. Dispos. 22, 392-399.
186. Stresser, D. M., Williams, D. E., Griffin, D. A., et al. (1995). Mechanism of tumor modulation by indole-3-carbinol: disposition and excretion in male Fischer 344 rats, Drug Metab. Dispos. 23, 965-974.
187. Sugimoto, K.-I., Ohmori, M., Tsuruoka, S., et al. (2001). Different effects of St. John's wort on the pharmacokinetics of simvastatin and pravastatin, Clin. Pharmacol. Ther. 70, 518-524.
188. Suzuki, H. and Sugiyama, Y. (2000). Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine, Eur. J. Pharm. Sci. 12, 3-12.
189. Takanaga, H., Ohnishi, A., Murakami, H., et al. (2000). Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects, Clin. Pharmacol. Ther. 67, 201-214.
190. Takano, H., Hasegawa, R., Fukuda, T., et al. (1998). Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cells, Eur. J. Pharmacol. 358, 289-294.
191. Tassaeenyakul, W., Guo, L.-Q., Fukuda, K., et al. (2000). Inhibition selectivity of grapefruit components on human cytochromes P450, Arch. Biochem. Biophys. 378, 356-363.
192. Thapliyal, R. and Maru, G. B. (2001). Inhibition of cytochrome P450 isozymes by curcumins in vitro and in vivo, Food Chem. Toxicol. 39, 541-547.
193. Trela, B. A. and Carlson, G. P. (1987). Effect of flavanone on mixed-function oxidase and conjugation reactions in rats, Xenobiotica 17, 11-16.
194. van Tellingen, O. (2001). The importance of drug-transporting P-glycoproteins in toxicology, Toxicol. Lett. 120, 31-41.
195. Vang, O., Jensen, M. B. and Autrup, H. (1990). Induction of cytochrome P450IA1 in rat colon and liver by indole-3-carbinol and 5,6-benzoflavone, Carcinogenesis 11, 1259-1263.
196. Vang, O., Jensen, M. B. and Autrup, H. (1991). Induction of cytochrome P-450IA1, IA2, IIB1 and IIE1 by broccoli in rat liver and colon, Chem.-Biol. Interact. 78, 85-96.
197. Vang, O., Frandsen, H., Hansen, K. T., et al. (2001). Biochemical effects of dietary intakes of different broccoli samples. I. Differential modulation of cytochrome P-450 activities in rat liver, kidney and colon, Metabolism 50, 1123-1129.
198. Venkatakrishnan, K., Greenblatt, D. J., Von Moltke, L. L., et al. (1998). Five distinct human cytochromes mediate amitriptyline N-demethylation in vitro: Dominance of CYP2C19 and 3A4, J. Clin. Pharmacol. 38, 112-121.
199. Venkatakrishnan, K., Von Moltke, L. L. and Greenblatt, D. J. (1999). Nortriptyline E-10hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): Implications for interactions with enzyme-inducing drugs, J. Clin. Pharmacol. 39, 567-577.
200. Vistisen, K., Poulsen, H. E. and Loft, S. (1992). Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine, Carcinogenesis 13, 1561-1568.
201. Wang, E. J., Casciano, C. N., Clement, R. P., et al. (2001). Inhibition of P-glycoprotein transport function by grapefruit juice psoralen, Pharm. Res. 18, 432-438.
202. Wargovich, M. J., Imada, O. and Stephen, L. C. (1992). Initiation and post-initiation chemopreventive effects of diallyl sulfide in esophageal carcinogenesis, Cancer Lett. 64, 39-42.
203. Weber, A., Jager, R., Borner, A., et al. (1996). Can grapefruit juice influence ethinylestradiol bioavailability?, Contraception 53, 41-47.
204. Wentworth, J. M., Agostini, M., Schwabe, J. W., et al. (2000). St. John's wort, a herbal antidepressant, activates the steroid X receptor, J. Endocrinol. 166, R11-R16.
205. Wills, R. B. H., Bone, K. and Morgan, M. (2000). Herbal products: active constituents, modes of action and quality control, Nutr. Res. Rev. 13, 47-77.
206. Wormhoudt, L. W., Commandeur, J. N. M. and Vermeulen, N. P. E. (1999). Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes, Crit. Rev. Toxicol. 29, 59-124.
207. Wortelboer, H. M., de Kruif, C. A., van Israel, A. J. J., et al. (1992a). Effects of cooked Brussels sprouts on cytochrome P-450 profile and phase-II enzymes in liver and small intestinal mucosa of the rat, Food Chem. Toxicol. 30, 17-27.
208. Wortelboer, H. M., van der Linden, E. C. M., de Kruif, C. A., et al. (1992b). Effects of indole-3-carbinol on biotransformation enzymes in the rat: in vivo changes in liver and small intestinal mucosa in comparison with primary hepatocyte cultures, Food Chem. Toxicol. 30, 589-599.
209. Yang, C. S., Chhabra, S. K., Hong, J.-Y., et al. (2001). Mechanisms of inhibition of chemical toxicity and carcinogenesis by diallyl sulfide (DAS) and related compounds, J. Nutr. 131, 1041S-1045S.
210. Yee, G. D., Stanley, D. L., Pessa, L., et al. (1995). Effect of grapefruit juice on blood cyclosporin concentration, Lancet 345, 955-956.
211. Yue, Q.-Y., Bergquist, C. and Gerdén, B. (2000). Safety of St. John's wort (Hypericum perforatum), Lancet 355, 576-577.
212. Zhang, Y., Talalay, P., Cho, G. C., et al. (1992). A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure, Proc. Natl. Acad. Sci. USA 89, 2399-2403.
213. Zimmerman, H. J. and Maddrey, W. C. (1995). Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of instances of therapeutic misadventure, Hepatology 22, 767-773.